These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 38446352)

  • 1. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities.
    Diwan R; Gaytan SL; Bhatt HN; Pena-Zacarias J; Nurunnabi M
    Drug Deliv Transl Res; 2024 Oct; 14(10):2743-2770. PubMed ID: 38446352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells.
    Zhang C; Teng Y; Li F; Ho W; Bai X; Xu X; Zhang XQ
    ACS Nano; 2023 Aug; 17(15):14852-14870. PubMed ID: 37490628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.
    Tacke F; Weiskirchen R
    Ann Transl Med; 2021 Apr; 9(8):729. PubMed ID: 33987427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics.
    Sristi ; Almalki WH; Karwasra R; Gupta G; Singh S; Sharma A; Sahebkar A; Kesharwani P
    Prog Mol Biol Transl Sci; 2024; 204():219-248. PubMed ID: 38458739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA- and miRNA-based therapeutics for liver fibrosis.
    Zhao Z; Lin CY; Cheng K
    Transl Res; 2019 Dec; 214():17-29. PubMed ID: 31476281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
    Wang X; Zhang W; Zeng S; Wang L; Wang B
    Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
    Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
    Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems.
    Liu J; Liu J; Mu W; Ma Q; Zhai X; Jin B; Liu Y; Zhang N
    ACS Nano; 2024 Aug; 18(32):20861-20885. PubMed ID: 39082637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1α.
    Cui Y; Guo C; Xia Z; Xue Y; Song B; Hu W; He X; Liang S; Wei Y; Zhang C; Wang H; Xu D; Zhang S; Fang J
    Acta Biomater; 2023 Oct; 169():500-516. PubMed ID: 37574157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review.
    Zhou L; Li Y; Liang Q; Liu J; Liu Y
    J Drug Target; 2022 Jul; 30(6):577-588. PubMed ID: 35179094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
    Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
    Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease.
    Sharma N; Chakole S; Wandile B
    Cureus; 2023 Oct; 15(10):e46946. PubMed ID: 38021670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis.
    Kurniawan DW; Jajoriya AK; Dhawan G; Mishra D; Argemi J; Bataller R; Storm G; Mishra DP; Prakash J; Bansal R
    J Control Release; 2018 Oct; 288():227-238. PubMed ID: 30219279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights.
    Janakiraman K; Krishnaswami V; Rajendran V; Natesan S; Kandasamy R
    Mater Today Commun; 2018 Dec; 17():200-213. PubMed ID: 32289062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-Conjugated siRNA Silencing
    Craig K; Abrams M; Amiji M
    Nucleic Acid Ther; 2023 Jan; 33(1):35-44. PubMed ID: 36318487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis.
    Tang M; Chen Y; Li B; Sugimoto H; Yang S; Yang C; LeBleu VS; McAndrews KM; Kalluri R
    FASEB J; 2021 May; 35(5):e21557. PubMed ID: 33855751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?
    La Sala L; Carlini V; Conte C; Macas-Granizo MB; Afzalpour E; Martin-Delgado J; D'Anzeo M; Pedretti RFE; Naselli A; Pontiroli AE; Cappato R
    Pharmacol Res; 2024 Mar; 201():107083. PubMed ID: 38309383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.